Emergent BioSolutions (FRA:ER4) Other Long Term Assets : €12.1 Mil (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Emergent BioSolutions Other Long Term Assets?

Emergent BioSolutions's other long-term assets for the quarter that ended in Mar. 2025 was €12.1 Mil.

Emergent BioSolutions's quarterly other long-term assets declined from Sep. 2024 (€18.5 Mil) to Dec. 2024 (€18.0 Mil) but then stayed the same from Dec. 2024 (€18.0 Mil) to Mar. 2025 (€12.1 Mil).

Emergent BioSolutions's annual other long-term assets declined from Dec. 2022 (€180.6 Mil) to Dec. 2023 (€178.2 Mil) and declined from Dec. 2023 (€178.2 Mil) to Dec. 2024 (€18.0 Mil).

Emergent BioSolutions Other Long Term Assets Historical Data

The historical data trend for Emergent BioSolutions's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Other Long Term Assets Chart

Emergent BioSolutions Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

93.21

51.51

180.59

178.17

18.05

Emergent BioSolutions Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															176.09	17.37	18.47	18.05	12.12

Emergent BioSolutions Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Emergent BioSolutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (FRA:ER4) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

EBS:USA 0IGA:UK ER4:Germany

Address

300 Professional Drive, Gaithersburg, MD, USA, 20879

Website

https://www.emergentbiosolutions.com

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Emergent BioSolutions Headlines

No Headlines